Martin Peter Carroll, MD

Vick B, Jurinovic V, Kuhbandner K, Lagally L, Latzko L, Arnreich C, Hänel G, Muth A, Schönung M, Kloos A, Rothenberg-Thurley M, Dufour AM, Schneider S, Holdt LM, Mura L, Klein F, Frank A, Mehra D, Fröhlich A, Bagnoli JW, André MC, Baldus CD, Carroll M, Dierks C, Ebinger M, Götze KS, Menéndez P, Récher C, Sahal A, Sarry JE, Thiede C, Velasco-Hernández T, Wei X, Klusmann JH, Enard W, von Bergwelt-Baildon M, Hiddemann W, Metzeler KH, Greif PA, Heuser M, Lipka DB, Subklewe M, Vosberg S, Herold T, Spiekermann K, Jeremias I. A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist , Hemasphere, 10: 2026,e70497

Pursley AJ, Kirmani U, Chen AL, Yu Z, Hanada K, Ade CM, Chien CD, Cha N, Flegel WA, Aplan PD, Carroll M, Taylor NN, Yang JC, Pavletic SZ, Pai SY, Leko V. HLA-A*11:01-Restricted T Cell Receptors Targeting Mutant NPM1 for Adoptive Cell Therapy in Acute Myeloid Leukemia , bioRxiv: 2026

Venkataraman R, Puccio N, Hsueh TY, Bonner EA, Chang FY, Arriaga-Gomez EA, Song A, Miyagawa T, Rahman J, Akinwande O, Sinha S, El Marabti E, Welner RS, Lu R, Ferrell PB, Carroll M, Appelbaum JS, Stirewalt DL, Abdel-Wahab O, Rongvaux A, Chen X, Naresh KN, Fica SM, Lee SC. Somatic DDX41 mutations confer neomorphic splicing activity in the pathogenesis of myelodysplastic neoplasms , bioRxiv: 2026

Peramangalam PS, Konde M, Karakaslar O, Wolf S, Zheng S, Salimov A, Surapally S, Griffioen M, Gu T, Rao S, Tenen DG, Oellerich T, van den Akker E, Carroll M, Saygin C, Pulikkan JA. Human CEBPA -N AML exhibits enhanced engraftment and a C/EBP α -p30-driven leukemic stem cell program , bioRxiv: 2026

Joshi SK, Maazi H, Pittsenbarger J, Garana BB, Kaempf A, Huang A, Gritsenko MA, Hutchinson-Bunch C, Weitz KK, Chu RK, Gosline SJC, Piehowski PD, Eisfeld AK, Carroll MP, Perl AE, Rodland KD, Chang BH, Revenko AS, Tyner JW, Druker BJ, Traer E. NRAS knockdown reverses monocytic cell state and resensitizes resistant FLT3-AML cells to gilteritinib , Blood: 2026

Buono R, Juarez D, Paul M, Skuli SJ, Wong IB, Tarnekar I, Ying Z, Le IMF, Chen WP, Zhang M, Wertheim G, Bakayoko A, Kruidenier M, Nicholas DA, Gupta P, Sebti SM, Konopleva M, Fleischman AG, Jang C, Carroll M, Fruman DA. Pitavastatin counteracts venetoclax resistance mechanisms including TP53 mutation in acute myeloid leukemia , Blood Neoplasia, 3: 2026,100296

Kumar A, Hamane K, Duault C, Lima-Junior JR, Jung DH, Qin H, Salcido S, Huang M, Guo X, Taghi Khani A, Sanchez Ortiz A, Ghoda L, Marcucci G, Lacayo NJ, Sakamoto KM, Hurtz C, Carroll M, Tasian SK, Geng H, Ji L, Armenian S, Izraeli S, Wu X, Maecker HT, Swaminathan S. Tumor-induced dendritic cell deregulation perturbs T cell proliferation and predicts clinical outcome in acute lymphoblastic leukemia , Cell Rep Med, 7: 2026,102945

Cao Z, Yu S, Peng J, Barrett DR, Liu Y, Sussman JH, Chen C, Thadi A, Liu L, Alikarami F, Xu J, Carroll MP, Tan K, Bernt KM, Shi J. CRISPR-based functional genomics for dissecting therapeutic dependency in primary acute myeloid leukemia samples , Mol Cell, 86: 2026,968-985

Neelamraju Y, Rapaport F, Gandara JA, Paudel BB, DeWolf S, Dunham N, Fan H, Lee T, Mayo MW, Othman J, Sheridan C, Sol-Church K, Solga MD, Wang L, Cripe LD, Dillon R, Kleppe M, Carroll M, Mason CE, Roboz GJ, Sun Z, Tallman MS, Zhang Y, Paietta E, Levine R, Melnick AM, Bekiranov S, Garrett-Bakelman FE. Elevated levels of TNF and its targets characterize better-risk older acute myeloid leukemia patients , Leukemia: 2026

Buono R, Juarez D, Paul M, Skuli SJ, Wong IB, Tarnekar I, Ying Z, Le I, Wertheim G, Bakayoko A, Kruidenier M, Sebti SM, Konopleva M, Fleischman AG, Jang C, Carroll M, Fruman DA. Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphate , bioRxiv: 2025